Showing results (81-90 of 214) with videos related to

Sort By:
Pageof 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2011
Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224sGrace A McComsey, Douglas Kitch, Paul E Sax, et al.
AIDS (London, England)|September 26, 2009
Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not menVincent Lo Re, Giovanni Guaraldi, Mary B Leonard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2016
Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 StudyFrank A Post, Pablo Tebas, Amanda Clarke, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2007
Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s)Pablo Tebas, Jiameng Zhang, Kevin Yarasheski, et al.
Vaccine|March 10, 2005
Plasmid vaccination of stable HIV-positive subjects on antiviral treatment results in enhanced CD8 T-cell immunity and increased control of viral "blips"Rob Roy MacGregor, Jean D Boyer, Kenneth E Ugen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2013
Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitisGregory P Bisson, Mooketsi Molefi, Scarlett Bellamy, et al.
AIDS (London, England)|May 28, 2021
Comparable HIV suppression by pegylated-IFN-α2a or pegylated-IFN-α2b during a 4-week analytical treatment interruptionEmmanouil Papasavvas, Livio Azzoni, Brian N Ross, et al.
AIDS (London, England)|January 4, 2014
Weight and lean body mass change with antiretroviral initiation and impact on bone mineral densityKristine M Erlandson, Douglas Kitch, Camlin Tierney, et al.
Pathogens & Immunity|August 27, 2021
Lack of Atorvastatin Effect on Monocyte Gene Expression and Inflammatory Markers in HIV-1-infected ART-suppressed Individuals at Risk of non-AIDS ComorbiditiesAnjana Yadav, Andrew V Kossenkov, Louise C Showe, et al.
The Journal of Infectious Diseases|April 19, 2008
Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapyTodd Hulgan, Pablo Tebas, Jeffrey A Canter, et al.
Pageof 22